Literature DB >> 17631504

Treatment of PC12 cells with nerve growth factor induces proteasomal degradation of T-cadherin that requires tyrosine phosphorylation of its cadherin domain.

Shoumei Bai1, Jharna Datta, Samson T Jacob, Kalpana Ghoshal.   

Abstract

T-cadherin (T-Cad), a unique member of the cadherin family of proteins, plays an important role in cell adhesion and cell signaling. Recently, we demonstrated that T-Cad is transcriptionally repressed by DNA methyltransferase 3b during nerve growth factor (NGF)-induced neuronal differentiation of PC12 cells. Here, we show that T-Cad expression is also regulated at the post-translational level by the proteasomal pathway in these cells, which is facilitated upon NGF treatment. Pulse-chase experiments demonstrated that NGF treatment significantly reduced the half-life of T-Cad. Degradation of T-Cad was blocked upon treatment of PC12 cells with the proteasomal inhibitor ZLLL or lactacystin. Ectopic expression of Cdh1 (CDC20 homolog 1), one of the substrate recognition components of anaphase promoting complex (E3 ligase), stimulated T-Cad degradation. Deletion of CD1, one of the five extracellular cadherin domains (CD), promoted degradation of T-Cad, especially in the presence of NGF. On the contrary, deletion of CD2 stabilized this protein maximally. Ubiquitination of different deletion mutants indicates that T-Cad harbors multiple ubiquitination signals. Furthermore, genistein, a protein-tyrosine kinase inhibitor, impeded T-Cad degradation in PC12 cells, implicating requirement of tyrosine phosphorylation in this process. Mutation at tyrosine 327 (Y327F) markedly increased the half-life of T-Cad, suggesting that phosphorylation of this tyrosine residue located within CD2 is critical for this process. These results show that T-cadherin is subject to dual regulation during NGF-induced differentiation of PC12 cells, namely transcriptional repression mediated by Dnmt3b and post-translational degradation through the proteasomal pathway. These data, together with the inhibitory role of T-Cad in neurite outgrowth of PC12 cells upon NGF treatment, underscore the significance of its stringent regulation during this differentiation process.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17631504      PMCID: PMC2243237          DOI: 10.1074/jbc.M700691200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

Review 1.  Cadherins in embryonic and neural morphogenesis.

Authors:  U Tepass; K Truong; D Godt; M Ikura; M Peifer
Journal:  Nat Rev Mol Cell Biol       Date:  2000-11       Impact factor: 94.444

Review 2.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

Authors:  M Karin; Y Ben-Neriah
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

3.  Negative regulation of Lck by Cbl ubiquitin ligase.

Authors:  Navin Rao; Sachiko Miyake; Alagarsamy Lakku Reddi; Patrice Douillard; Amiya K Ghosh; Ingrid L Dodge; Pengcheng Zhou; Norvin D Fernandes; Hamid Band
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

4.  Differential interaction of plakoglobin and beta-catenin with the ubiquitin-proteasome system.

Authors:  E Sadot; I Simcha; K Iwai; A Ciechanover; B Geiger; A Ben-Ze'ev
Journal:  Oncogene       Date:  2000-04-13       Impact factor: 9.867

Review 5.  The SCF ubiquitin ligase: an extended look.

Authors:  Peter K Jackson; Adam G Eldridge
Journal:  Mol Cell       Date:  2002-05       Impact factor: 17.970

6.  Identification of a new APC/C recognition domain, the A box, which is required for the Cdh1-dependent destruction of the kinase Aurora-A during mitotic exit.

Authors:  Laurie E Littlepage; Joan V Ruderman
Journal:  Genes Dev       Date:  2002-09-01       Impact factor: 11.361

7.  Aryl hydrocarbon receptor ligands repress T-cadherin expression in vascular smooth muscle cells.

Authors:  Thomas Niermann; Sanja Schmutz; Paul Erne; Thérèse Resink
Journal:  Biochem Biophys Res Commun       Date:  2003-01-24       Impact factor: 3.575

8.  Cadherin-13, a mediator of calcium-dependent cell-cell adhesion, is silenced by methylation in chronic myeloid leukemia and correlates with pretreatment risk profile and cytogenetic response to interferon alfa.

Authors:  Jose Roman-Gomez; Juan A Castillejo; Antonio Jimenez; Francisco Cervantes; Concepcion Boque; Lourdes Hermosin; Angel Leon; Albert Grañena; Dolors Colomer; Anabel Heiniger; Antonio Torres
Journal:  J Clin Oncol       Date:  2003-04-15       Impact factor: 44.544

9.  Aberrant methylation of the CDH13 (H-cadherin) promoter region in colorectal cancers and adenomas.

Authors:  Shinichi Toyooka; Kiyomi O Toyooka; Kenichi Harada; Kuniharu Miyajima; Prakash Makarla; Ubaradka G Sathyanarayana; Jing Yin; Fumiaki Sato; Narayan Shivapurkar; Stephen J Meltzer; Adi F Gazdar
Journal:  Cancer Res       Date:  2002-06-15       Impact factor: 12.701

Review 10.  The cadherin superfamily: diversity in form and function.

Authors:  B D Angst; C Marcozzi; A I Magee
Journal:  J Cell Sci       Date:  2001-02       Impact factor: 5.285

View more
  6 in total

1.  Nerve growth factor induces cell cycle arrest of astrocytes.

Authors:  Andrea B Cragnolini; Marta Volosin; Yangyang Huang; Wilma J Friedman
Journal:  Dev Neurobiol       Date:  2012-06       Impact factor: 3.964

Review 2.  Anchoring junctions as drug targets: role in contraceptive development.

Authors:  Dolores D Mruk; Bruno Silvestrini; C Yan Cheng
Journal:  Pharmacol Rev       Date:  2008-05-15       Impact factor: 25.468

3.  T-cadherin structures reveal a novel adhesive binding mechanism.

Authors:  Carlo Ciatto; Fabiana Bahna; Niccolò Zampieri; Harper C VanSteenhouse; Phini S Katsamba; Goran Ahlsen; Oliver J Harrison; Julia Brasch; Xiangshu Jin; Shoshana Posy; Jeremie Vendome; Barbara Ranscht; Thomas M Jessell; Barry Honig; Lawrence Shapiro
Journal:  Nat Struct Mol Biol       Date:  2010-02-28       Impact factor: 15.369

4.  Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1.

Authors:  Mohd W Nasser; Jharna Datta; Gerard Nuovo; Huban Kutay; Tasneem Motiwala; Sarmila Majumder; Bo Wang; Saul Suster; Samson T Jacob; Kalpana Ghoshal
Journal:  J Biol Chem       Date:  2008-09-25       Impact factor: 5.157

5.  MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib.

Authors:  Shoumei Bai; Mohd W Nasser; Bo Wang; Shu-Hao Hsu; Jharna Datta; Huban Kutay; Arti Yadav; Gerard Nuovo; Pawan Kumar; Kalpana Ghoshal
Journal:  J Biol Chem       Date:  2009-09-02       Impact factor: 5.157

Review 6.  PI3K/Akt and HIF‑1 signaling pathway in hypoxia‑ischemia (Review).

Authors:  Zhen Zhang; Li Yao; Jinhua Yang; Zhenkang Wang; Gang Du
Journal:  Mol Med Rep       Date:  2018-08-09       Impact factor: 2.952

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.